Virtual Library
Start Your Search
N. Kondo
Author of
-
+
P3.09 - Mesothelioma (ID 725)
- Event: WCLC 2017
- Type: Poster Session with Presenters Present
- Track: Mesothelioma
- Presentations: 2
- Moderators:
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.09-004 - Routine Clinical Parameters Can Stratify Survival Characteristics in Mesothelioma Patients Undergoing Surgery (ID 8318)
09:30 - 09:30 | Author(s): N. Kondo
- Abstract
Background:
Malignant pleural mesothelioma (MPM) is a rare cancer with a heterogeneous prognosis. We have previously described and validated a prognostic model using a classification and regression tree (CART) model to analyse the interaction of multiple variables with survival in a broad MPM population.(1) We aimed to test the performance of our model on a population with MPM who had surgical intervention.
Method:
Cases from Australia and Japan with confirmed MPM who underwent surgery were analysed with clinical variables available at the time of referral recorded. The model uses combinations of different variables (Table 1) to stratify participants into different risk groups (1-4) and the survival characteristics were compared using the Log Rank test. Figure 1
Result:
A total of 289 cases were included (205 from Australia and 84 from Japan) who had surgery between 1991-2016. Overall median survival was 34.6 (IQR 17.5-56.1) months; median age 63.0 (IQR 57.0-67.8) years, 240/289 (83.0%) were male. Epithelioid MPM was the most common subtype (80.9%), weight loss was present in 36.6%, dyspnoea in 54.4%, chest pain in 29.0% and 91.8% had an ECOG performance status of 0. EPP was the most common operation performed (56.7%), followed by pleurectomy/decortication in 30.4%. There were no clinically meaningful differences between the cohorts; 40 patients were alive at censure. Survival across the risk groups was significantly different (Log Rank test p<0.0001). The group with the longest survival (median 78.1, IQR 28.1-152.4 months) had no weight loss, Hb >153g/L and serum albumin >43g/L at the time of referral to specialist surgical centre.
Conclusion:
The combination and interaction of simple, clinical variables available early after diagnosis of MPM is able to stratify survival and discriminate higher and lower risk of death in high performance status patients
-
+
P3.09-009 - Fourteen Cases Study of 5 Year Survivors of Malignant Pleural Mesothelioma Following Extrapleural Pneumonectomy (ID 9917)
09:30 - 09:30 | Author(s): N. Kondo
- Abstract
Background:
We performed extrapleural pneumonectomy (EPP) as curative intent surgery for malignant pleural mesothelioma (MPM) from 2004 to 2012. We investigated that factors associated with long term survival in our current cases.
Method:
We retrospectively reviewed some factors concerning the patients underwent EPP from April 2004 to march 2017 and past more than 5 years after operation. We analyzed age, sex, epidemiology, side, clinical stage, measurements of pleural thickness, the value of SUV max of PET-CT, pathological stage, length from EPP to recurrence and end results.
Result:
A total of 54 patients were enrolled to this study. Six patients who had exploratory thoracotomy and three patients who had not macroscopic complete resection were excluded. Overall, 14 patients (31%) survived at least 5 years (Group S), and 31 patients (68%) survived less than 5 years (Group N). All patients had EPP. In Group S, 10 males (71%) and 4 females (29%); age when they had operation ranged from 37 to 69 years with a median age of 57.5 years. All of them, histological subtypes were epithelial type. By the comparison between Group S and Group N, there were significant differences among the value of SUV max of PET-CT validation of pre and post neoadjvant chemotherapy(＜3.0 vs ≧3.0, p=0.03), length from EPP to radiotherapy (＜60 days vs ≧60 days, p=0.02), length from EPP to recurrence (＜1 year vs ≧1 year, p=0.0001).
Conclusion:
More than 30% patients survived at least 5 years in this study. One patient survived more than 10 years. Another patient survived more than 8 years without recurrence. This case suggest that cancer of the patient possibly cured radically. In the future, we need comparison the prognosis, complication, quality of life (QOL) between the patients who underwent EPP and the patients who underwent pleurectomy/decortications (P/D).
